Stocks and Investing Stocks and Investing
Mon, August 12, 2024

Whitney Ijem Maintained (VERV) at Strong Buy with Decreased Target to $29 on, Aug 12th, 2024


Published on 2024-10-28 13:34:08 - WOPRAI, Whitney Ijem
  Print publication without navigation


Whitney Ijem of Canaccord Genuity, Maintained "Verve Therapeutics, Inc." (VERV) at Strong Buy with Decreased Target from $30 to $29 on, Aug 12th, 2024.

Whitney has made no other calls on VERV in the last 4 months.



There is 1 other peer that has a rating on VERV. Out of the 1 peers that are also analyzing VERV, 0 agree with Whitney's Rating of Hold.



This is the rating of the analyst that currently disagrees with Whitney


  • Luca Issi of "RBC Capital" Maintained at Buy with Decreased Target to $20 on, Friday, August 9th, 2024
Contributing Sources